Pharmaceutical

LiveWorld Reports First Quarter 2025 Financial Results

LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc.…

8 months ago

Dogwood Therapeutics Announces First Quarter 2025 Financial Results

- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Study - -…

8 months ago

Cryoport Reports First Quarter 2025 Financial Results

Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over yearQ1 2025 revenue from continuing operations of…

8 months ago

Rx for Growth: Greg Voyles Appointed to Accelerate Imre’s Healthcare Mission

Voyles' appointment sets the stage for Imre's ability to deliver new solutions for healthcare clients navigating an era of rapid…

8 months ago

Hospital PMI® at 55%; April 2025 Hospital ISM® Report On Business®

TEMPE, Ariz., May 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in April for the 20th consecutive…

8 months ago

Tobin Scientific Closes $65M Investment to Accelerate Growth Across Life Sciences Infrastructure

BEVERLY, Mass., May 7, 2025 /PRNewswire/ -- Tobin Scientific, a leading provider of cGMP storage, biorepository services, and specialized logistics for…

8 months ago

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies,…

8 months ago

Supreme Group Acquires Nimble Works and Vital Works, Strengthening Brand Strategy and Creative Execution

Eighth agency acquisition bolsters Supreme Group's ability to deliver agile, insight-driven creative solutions for the healthcare and life sciences industries…

8 months ago

Citizen Health Partner to Support Drug Development and Long-Term Patient Outcomes in PKP2 Cardiomyopathy

Collaboration aims to enhance clinical study experience and accelerate therapeutic innovation for arrhythmogenic cardiomyopathy caused by PKP2 mutations SAN FRANCISCO…

8 months ago